GlassScriptPhysician profile
William L Wilson
NPI 1972598316
$1,719.47
in general payments reported to CMS, 2019-2025
20 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $960 · 2020: $474 · 2021: $285.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $694.44 | 2019-2021 | |
| Scilex Pharmaceuticals INC. | $367.45 | 2019-2021 | |
| Allergan, INC. | $76.94 | 2019-2021 | |
| Stimwave Technologies Incorporated | $76.84 | 2019-2020 | |
| Electronic Waveform Lab, INC. | $66.29 | 2019 | |
| Boston Scientific Corporation | $53.33 | 2020-2021 | |
| Almatica Pharma LLC | $45.91 | 2020-2021 | |
| Biodelivery Sciences International, INC. | $39.65 | 2019 | |
| Arbor Pharmaceuticals, INC. | $34.37 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $33.16 | 2020 | |
| Lilly USA, LLC | $33.10 | 2019 | |
| Tersera Therapeutics LLC | $31.58 | 2019 | |
| Pfizer INC. | $31.20 | 2019 | |
| Nevro Corp. | $23.87 | 2019 | |
| Grt US Holding, INC. | $22.50 | 2020 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $21.40 | 2019 | |
| Collegium Pharmaceutical, INC. | $18.75 | 2019 | |
| Daiichi Sankyo INC. | $18.67 | 2019 | |
| Shionogi INC | $15.67 | 2019 | |
| Kaleo, INC. | $14.35 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Wilson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.